800-845-6913
Tuteur & Associates, LLC | Knowledge is Power.
Have you or a loved on been injured by the use of Trasylol
Trasylol-Injury-Lawyers.com
Contact Us
Contact us today.
Articles
- What Bayer Knew About Trasylol: Insider Unveils Fraud & Corruption
- Supreme Court Ruling Supports Drug Lawsuits
- Another Trasylol Study Finds Cheaper Drugs Less Risky
- Latest Canadian Trasylol Study: Alternative Medications are Safer and Cheaper
- Wrongful Death Lawsuit Filed Against Bayer Over Drug Trasylol
- Trasylol Alternatives Less Risky, Cheaper and Nearly as Effective: New Study
- Another Study Warns of Risk From Cardiac Surgery Drug Trasylol
- Trasylol Named in Two Lawsuits in St. Clair County, IL
- Bayer Withdraws Heart Surgery Drug from U.S. Market Following New Study Results Revealing Harm
- A Thousand Patients Killed Each Month by Cardiac Bypass Anti-Bleeding Drug Trasylol
- The Trasylol Story Illustrates Why FDA Preemption is Bad Public Policy
- The Trasylol heart surgery time bomb: Trasylol's potential dangers remain for up to ten years after the operation
- Canadian BART study confirms danger from heart surgery drug Trasylol
- Study published in New England Journal of Medicine hammers last nail in the coffin for Bayer's Trasylol
- Study finds Bayer's Trasylol used during open-heart surgery increases death rate, renal failure, dialysis
- Bayer pulls Trasylol supplies after study reveals increased risk of renal failure, dialysis and death after open-heart surgery
- Bayer will begin pulling remaining stock of Trasylol
- Trasylol lawsuits against Bayer mount
- Trasylol kidney failure death unnecessary
- Bayer CEO says faces 78 Trasylol lawsuits in U.S.
- Lawsuits seek damages from Bayer over anti-bleeding drug Trasylol
- Heart drug Trasylol pulled from market after 50 percent increase in death rate discovered
- Trasylol Lawsuits Filed, Bayer Stock Price Drops Slightly
- Trasylol (aprotinin injection): Protect Consumers' Right to Sue Drugmaker
- A Lone Holdout? The Duke Doc & Bayer’s Trasylol
- Bayer Posts 'Best Ever' Yearly Results, Expect Trasylol Lawsuits
- Studies Link Bayer Drug Trasylol to Patient Deaths
- More Trouble for Trasylol
- New Studies Show Risks of Antibleeding Drug Trasylol
- More Evidence of Danger From Heart Surgery Drug Trasylol
- Aprotinin (Trasylol) Use in CABG Again Shows Extra Mortality Risk
- Comment: 60 Minutes Blows the Lid off the FDA’s Trasylol Scandal
- Too Many Deaths Caused by Trasylol: 22,000 People
- Delayed Bayer Drug Trasylol Recall Blamed for 22,000 Deaths
- 60 Minutes to Air Report on Dangers of Trasylol
- 22,000 Deaths From Delayed Recall of Trasylol
- 60 Minutes: FDA Trasylol Failure Could Have Killed Thousands, Researcher Says
- Researcher Estimates 22,000 Lives Could Have Been Saved Had Trasylol Been Pulled Earlier
- Aprotinin (Trasylol) Kidney Risk Linked to Off-Pump Bypass Plus ACE Inhibitors
- Trasylol and Ace Inhibitors Tied to Kidney Risk with Cardiac Surgeries
- Bayer's Trasylol Boosts Death, Kidney Risks After Heart Surgery (2-21-08)
Headlines
Lawsuits seek damages from Bayer over anti-bleeding drug Trasylol
April 22, 2008
WEST PALM BEACH, Fla. — Eight lawsuits filed in a Florida federal court are seeking damages from Bayer AG over a controversial anti-bleeding drug.
The lawsuits involving the drug Trasylol were filed in federal court in West Palm Beach by St. Louis-based law firm Carey & Danis. The firm represents families of people who died after they were given the drug following heart surgery.
Trasylol was on the market for 14 years until 2007, when Bayer stopped selling it. Several studies have documented the drug’s dangers, but Bayer has challenged some of those findings.
The lawsuits seek unspecified damages. They claim Bayer sold a defective drug and failed to issue warnings about its risks. Bayer officials did not immediately respond to an e-mail Tuesday seeking comment.